4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001638599-17-000662
Director bought 338,791 shares at $17.71 ($5,999,989)
From the SEC's structured data for this filing
Trades in this filing
SPRINGER TIMOTHY A · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-06-27 | Purchase : show line 1 in the form | +338,791 | $17.71 | $5,999,989 | 355,413 | D |
| Open-market purchases · 338,791 sh · avg $17.71 · $5,999,989 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2017-06-27 | Purchase : show line 2 in the form Warrant (right to buy) | +79,130 | $0.13 | $9,891 | $17.71 | 2022-06-27 | 79,130 | 79,130 | D |
Loading xslF345X03/doc4_4824.xml…